Concepedia

Juan J. Miret

JJ

Statistics

Publications

7

Citations

1K

H-Index

7

Active since

1992

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Massachusetts General Hospital

Broad Institute

Novartis (United States)

Juan J. Miret is an author at Dana-Farber Cancer Institute specializing in oncology, cancer immunotherapy, and life sciences.

ORCID

Publications per year

1992–2022

7

Publications

7

<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids

Russell W. Jenkins, Amir Reza Aref, Patrick H. Lizotte et al. · Cancer Discovery · 2017 · 585 citations

, , +17

Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity

Juan J. Miret, Paul T. Kirschmeier, Shohei Koyama et al. · Journal for ImmunoTherapy of Cancer · 2019 · 155 citations · Full text

, , +16

Activation of Tumor-Cell STING Primes NK-Cell Therapy

Erik H. Knelson, Elena V. Ivanova, Mubin Tarannum et al. · Cancer Immunology Research · 2022 · 88 citations · Full text

, , +17

Instability of CAG and CTG Trinucleotide Repeats in <i>Saccharomyces cerevisiae</i>

Juan J. Miret, Luis Pessoa-Brandão, Robert S. Lahue · Molecular and Cellular Biology · 1997 · 87 citations · Full text

, , +17

Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade

Kartik Sehgal, Andrew Portell, Elena V. Ivanova et al. · Journal of Clinical Investigation · 2020 · 73 citations · Full text

, , +17

1–5 of 7